RNA Polymerase I Inhibition with CX‐5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma

Overview of attention for article published in British Journal of Haematology, March 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 68 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 18,694 followers.

RT @Myeloma_Doc: #Myeloma Paper of the Day: Study showing that targeting RNA polymerase I with CX-5461 down-regulates ribosomal gene transc…

11 Apr 2024

Reply Repost Favourite

RT @Myeloma_Doc: #Myeloma Paper of the Day: Study showing that targeting RNA polymerase I with CX-5461 down-regulates ribosomal gene transc…

10 Apr 2024

Reply Repost Favourite

Well done Kylee

10 Apr 2024

Reply Repost Favourite

#Myeloma Paper of the Day: Study showing that targeting RNA polymerase I with CX-5461 down-regulates ribosomal gene transcription and shows anti-myeloma effects in vitro & in vivo: https://t.co/7Dgzl0vkCW. Consistent with our prior work from 2017: http

10 Apr 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.